Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
FEBS Lett ; 385(3): 233-7, 1996 May 06.
Artigo em Inglês | MEDLINE | ID: mdl-8647258

RESUMO

The increased glucose consumption of many tumor cells depends to a large extent on the overexpression of hexokinase Type II. In a previous study we isolated and sequenced the hepatoma Type II hexokinase promoter and showed that it is activated by glucose in the highly glycolytic AS-30D hepatoma cell line under study, but not activated in control hepatocytes [Mathupala, S.P., Rempel, A. and Pedersen, P.L. (1995) J. Biol. Chem. 270, 16918-16925]. Here we report that the promoter of the hexokinase Type II gene is maximally activated by glucose at concentrations above 5 mM. Moreover, the data strongly suggest that glucose can act alone without requirement for metabolism. Also, glucose-mediated promoter activation is markedly potentiated by cAMP. This response may serve as a strategy for cancer cells to maintain the hexokinase transcription rate high to ensure an efficient glucose utilization even under conditions where carbohydrates are limiting.


Assuntos
AMP Cíclico/farmacologia , Glucose/metabolismo , Glucose/farmacologia , Hexoquinase/genética , Neoplasias Hepáticas Experimentais/enzimologia , Regiões Promotoras Genéticas/efeitos dos fármacos , Sulfonamidas , 1-Metil-3-Isobutilxantina/farmacologia , Animais , Bucladesina/farmacologia , Colforsina/farmacologia , AMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Regulação Neoplásica da Expressão Gênica , Hexoquinase/antagonistas & inibidores , Hexoquinase/metabolismo , Hexoses/farmacologia , Isoquinolinas/farmacologia , Manoeptulose/farmacologia , Ratos , Transdução de Sinais , Transfecção , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...